BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17852435)

  • 1. Predictive factors of septic shock and mortality in neutropenic patients.
    Ramzi J; Mohamed Z; Yosr B; Karima K; Raihane B; Lamia A; Hela BA; Zaher B; Balkis M
    Hematology; 2007 Dec; 12(6):543-8. PubMed ID: 17852435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R; Achour M; Amor RB; Aissaoui L; Bouterâa W; Kacem K; Lakhal RB; Abid HB; BelHadjAli Z; Turki A; Meddeb B
    Hematology; 2010 Feb; 15(1):28-32. PubMed ID: 20132659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections.
    Jeddi R; Ghédira H; Ben Amor R; Turki A; Kacem K; Ben Abdennebi Y; Ben Lakhal R; Aissaoui L; Ben Abid H; Bel Hadjali Z; Meddeb B
    Hematology; 2011 May; 16(3):160-5. PubMed ID: 21669056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
    Roongpoovapatr P; Suankratay C
    J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M; Thamlikitkul V
    J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in neutropenic patients with severe sepsis or septic shock.
    Legrand M; Max A; Peigne V; Mariotte E; Canet E; Debrumetz A; Lemiale V; Seguin A; Darmon M; Schlemmer B; Azoulay E
    Crit Care Med; 2012 Jan; 40(1):43-9. PubMed ID: 21926615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies.
    Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S
    Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteremia and septic shock after solid-organ transplantation.
    Candel FJ; Grima E; Matesanz M; Cervera C; Soto G; Almela M; Martínez JA; Navasa M; Cofán F; Ricart MJ; Pérez-Villa F; Moreno A
    Transplant Proc; 2005 Nov; 37(9):4097-9. PubMed ID: 16386636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock.
    Chumbita M; Puerta-Alcalde P; Gudiol C; Garcia-Pouton N; Laporte-Amargós J; Ladino A; Albasanz-Puig A; Helguera C; Bergas A; Grafia I; Sastre E; Suárez-Lledó M; Durà X; Jordán C; Marco F; Condom M; Castro P; Martínez JA; Mensa J; Soriano A; Carratalà J; Garcia-Vidal C
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0174421. PubMed ID: 34843387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients.
    Bothra M; Seth R; Kapil A; Dwivedi SN; Bhatnagar S; Xess I
    Indian J Pediatr; 2013 Apr; 80(4):297-302. PubMed ID: 23255077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia.
    Aydemir H; Piskin N; Kokturk F; Gökmen A; Akduman D
    J Geriatr Oncol; 2013 Apr; 4(2):190-5. PubMed ID: 24071544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies.
    Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
    Engel A; Mack E; Kern P; Kern WV
    Infection; 1998; 26(4):213-21. PubMed ID: 9717678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
    Kim SH; Kwon JC; Choi SM; Lee DG; Park SH; Choi JH; Yoo JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Ann Hematol; 2013 Apr; 92(4):533-41. PubMed ID: 23161391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients.
    Vänskä M; Koivula I; Hämäläinen S; Pulkki K; Nousiainen T; Jantunen E; Juutilainen A
    Haematologica; 2011 Sep; 96(9):1385-9. PubMed ID: 21880642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies.
    Calik S; Ari A; Bilgir O; Cetintepe T; Yis R; Sonmez U; Tosun S
    Saudi Med J; 2018 Sep; 39(9):878-885. PubMed ID: 30251730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
    Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
    J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.